Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
5.53
-0.13 (-2.30%)
At close: Mar 6, 2026, 4:00 PM EST
5.45
-0.08 (-1.45%)
Pre-market: Mar 9, 2026, 7:05 AM EST
Evolus Employees
Evolus had 334 employees as of December 31, 2025. The number of employees increased by 2 or 0.60% compared to the previous year.
Employees
334
Change
2
Growth
0.60%
Revenue / Employee
$889,749
Profits / Employee
-$154,614
Market Cap
359.78M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 334 | 2 | 0.60% |
| Sep 30, 2025 | 329 | 7 | 2.17% |
| Jun 30, 2025 | 394 | 90 | 29.61% |
| Mar 31, 2025 | 372 | 93 | 33.33% |
| Dec 31, 2024 | 332 | 59 | 21.61% |
| Sep 30, 2024 | 322 | 76 | 30.89% |
| Jun 30, 2024 | 304 | 89 | 41.40% |
| Mar 31, 2024 | 279 | 55 | 24.55% |
| Dec 31, 2023 | 273 | 58 | 26.98% |
| Sep 30, 2023 | 246 | 33 | 15.49% |
| Jun 30, 2023 | 215 | 41 | 23.56% |
| Mar 31, 2023 | 224 | 50 | 28.74% |
| Dec 31, 2022 | 215 | 48 | 28.74% |
| Sep 30, 2022 | 213 | 64 | 42.95% |
| Jun 30, 2022 | 174 | 44 | 33.85% |
| Mar 31, 2022 | 174 | 68 | 64.15% |
| Dec 31, 2021 | 167 | 48 | 40.34% |
| Sep 30, 2021 | 149 | 24 | 19.20% |
| Jun 30, 2021 | 130 | 3 | 2.36% |
| Mar 31, 2021 | 106 | -114 | -51.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 420 |
| Lifecore Biomedical | 406 |
| Ironwood Pharmaceuticals | 253 |
| Akebia Therapeutics | 194 |
| Aquestive Therapeutics | 142 |
EOLS News
- 5 days ago - Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability1 Beginning in 2026 - Business Wire
- 11 days ago - Evolus to Participate in The Leerink Partners Global Healthcare Conference - Business Wire
- 19 days ago - Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026 - Business Wire
- 23 days ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue - Business Wire
- 4 months ago - Evolus Reports Third Quarter 2025 Financial Results - Business Wire
- 4 months ago - Evolus to Participate in 2025 Stifel Healthcare Conference - Business Wire
- 4 months ago - Evolus to Report Third Quarter Financial Results on November 5, 2025 - Business Wire